INSTITUTO FINLAY; CENTRO DE INVESTIGACION-PRODUCCION DE VACUNAS Y SUEROS
发明人:
PEREZ MARTIN, OLIVER GERMAN,PEREZ CUELLO, MARIBEL,CABRERA BLANCO, OSMIR,BALBOA GONZALEZ, JULIO ANTONIO,LASTRE GONZALEZ, MIRIAM DE SAN JUAN BOSCO,ZAYAS VIGNIER, CARIDAD, CARIDAD,GONZALEZ AZNAR, ELIZABE
申请号：
EP11777295
公开号：
EP2548572A4
申请日:
2011.05.05
申请国别(地区):
EP
年份:
2013
代理人:
摘要：
The invention relates to the field of vaccinal compositions for the effective or preventive treatment of vertically transmitted infections, especially malaria and preferably human malaria caused by Plasmodium falciparum. The technical aim of the invention is to use the tolerogens transferred, at an early stage, from the mother to the foetus/newborn and to formulate them with potent adjuvants that are inducers of Th1 and cytotoxic T-cell responses in order to use same in prophylactic or therapeutic vaccines against vertically transmitted infections, especially malaria. The use of said formulations at early ages via the parenteral route or via the mucosal route or both at the same time reverts the tolerance induced by the transfer of tolerogens, thereby inducing protective responses.
